US OptionsDetailed Quotes
RIGL241220C37000
- 0.20
- 0.000.00%
15min DelayClose Dec 16 16:00 ET
0.00High0.00Low
0.20Open0.20Pre Close0 Volume1 Open Interest37.00Strike Price0.00Turnover398.69%IV94.36%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.0696Delta0.0178Gamma95.70Leverage Ratio-0.1210Theta0.0001Rho6.66Eff Leverage0.0025Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet